// App-Quantinova.ai

4725 : Use of Growth Factors in Treatment of Hepatitis C Viral Infection in Cancer Patients

Researchers

Presenter

  • Parag Mahale

Principal Investigators

  • Abhinav Saxena

  • Vahid Afshar-Kharghan

  • Shuju Feng

  • Michael H. Kroll

  • Thein H Oo

Medical Centers

  • University of Texas School of Public Health, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hematological malignancies

  • Alpha-thalassemia myelodysplasia syndrome

  • Liver cancer

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Thrombocytopenia

  • Cervical cancer

  • Uveal melanoma

  • Breast cancer

  • Hepatitis C

  • Glioblastoma

  • Solid malignancies

  • Neutropenia

  • Venous thrombosis

  • Lymphomas

  • Melanoma

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Peginterferon alfa-2a

  • Pegfilgrastim

  • Eltrombopag

  • Romiplostim

  • Boceprevir

  • Filgrastim

  • Telaprevir

  • Interferon

  • Ribavirin

  • Erythropoietin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved